SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-021371
Filing Date
2021-03-17
Accepted
2021-03-17 16:41:23
Documents
2
Period of Report
2021-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2147
2 POA DOCUMENT poa.txt EX-24.3_973869 4055
  Complete submission text file 0001209191-21-021371.txt   7819
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O KURA ONCOLOGY, INC. 3033 SCIENCE PARK RD, SUITE 220 SAN DIEGO CA 92121
Business Address
Martell Bridget A (Reporting) CIK: 0001629627 (see all company filings)

Type: 3 | Act: 34 | File No.: 033-80623 | Film No.: 21751075